Fed­er­al agency op­pos­es J&J's new 340B dis­count mod­el, promis­es to take 'ac­tions as war­rant­ed'

The fed­er­al gov­ern­ment is chal­leng­ing John­son & John­son’s plan to change how some hos­pi­tals re­ceive drug price dis­counts un­der the 340B pro­gram.

Last week, J …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER